PubRank

Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation

Clinical Trial ID NCT00264420

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00264420

Top papers

Rank Title Journal Year PubWeight™‹?›
101 Bisphosphonate treatment of lytic bone metastases. Drugs Aging 1999 0.82
102 A dose-finding study of zoledronate in hypercalcemic cancer patients. J Bone Miner Res 1999 0.81
103 Effects of a new bisphosphonate (AHBuBP) on osteolysis induced by human prostate cancer cells in nude mice. J Urol 1990 0.81
104 Clinical research update: zoledronate. Cancer 1997 0.81
105 Effects of intravenous diphosphonates on renal function. Lancet 1983 0.81
106 Renal tolerability profile of novel, potent bisphosphonates in two short-term rat models. Pharmacol Toxicol 1997 0.80
107 Osteoclasts and the resorption of bone by transplanted mammary carcinoma in rats. Br J Cancer 1985 0.79
108 Pyridinium cross-links as urinary markers of bone metastases in patients with prostate cancer. Br J Urol 1996 0.79
109 Aminohydroxypropylidene bisphosphonate (APD) treatment for tumor-associated hypercalcemia: a randomized comparison between a 3-day treatment and single 24-hour infusions. J Bone Miner Res 1989 0.78
110 Humoral hypercalcemia of malignancy. Bone Miner 1988 0.78
111 Pamidronate. Ann Pharmacother 1992 0.78
112 Effect of the combination of docetaxel, zoledronic acid, and a COX-2 inhibitor on the growth of human breast cancer cell lines. Am J Clin Oncol 2003 0.77
113 Anti-tumour activity of bisphosphonates in human myeloma cells. Leuk Lymphoma 1998 0.76
114 Fast (4-h) or slow (24-h) infusions of pamidronate disodium (aminohydroxypropylidene diphosphonate (APD)) as single shot treatment of hypercalcaemia. Bone Miner 1990 0.75
115 Bone metastases. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 0.75
116 The final report of the expert panel for the radiation oncology bone metastasis work group of the American College of Radiology. Int J Radiat Oncol Biol Phys 1998 0.75
117 Short-term metabolic effects of pamidronate in patients with prostatic carcinoma and bone metastases. Lancet 1989 0.75
118 Inhibition by a new bisphosphonate (AHBuBP) of bone resorption induced by the MBT-2 tumor of mice. Cancer 1991 0.75
119 Use of pamidronate for multiple myeloma osteolytic lesions. Lancet 1990 0.75
Next 100